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Changes in duodenal tissue-
associated microbiota following 
hookworm infection and 
consecutive gluten challenges  
in humans with coeliac disease
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A reduced diversity of the gastrointestinal commensal microbiota is associated with the development 
of several inflammatory diseases. Recent reports in humans and animal models have demonstrated 
the beneficial therapeutic effects of infections by parasitic worms (helminths) in some inflammatory 
disorders, such as inflammatory bowel disease (IBD) and coeliac disease (CeD). Interestingly, these 
studies have described how helminths may alter the intestinal microbiota, potentially representing 
a mechanism by which they regulate inflammation. However, for practical reasons, these reports 
have primarily analysed the faecal microbiota. In the present investigation, we have assessed, for the 
first time, the changes in the microbiota at the site of infection by a parasitic helminth (hookworm) 
and gluten-dependent inflammation in humans with CeD using biopsy tissue from the duodenum. 
Hookworm infection and gluten exposure were associated with an increased abundance of species 
within the Bacteroides phylum, as well as increases in the richness and diversity of the tissue-resident 
microbiota within the intestine, results that are consistent with previous reports using other helminth 
species in humans and animal models. Hence, this may represent a mechanism by which parasitic 
helminths may restore intestinal immune homeostasis and exert a therapeutic benefit in CeD, and 
potentially other inflammatory disorders.
A number of studies have reported the beneficial effects of experimental helminth infections on the pathology of 
a range of human autoimmune and allergic inflammatory disorders of the gastrointestinal tract, including inflam-
matory bowel disease (IBD) and coeliac disease (CeD)1–6. Indeed, according to the ‘Hygiene Hypothesis’ and the 
‘Old Friends Theory’, exposure to pathogens (including parasitic helminths) during childhood is important for 
the development of regulatory immune mechanisms that, in turn, contribute to the prevention of diseases associ-
ated with inappropriate immune reactions against harmless stimuli7. As a consequence, controlled infections with 
selected parasitic helminths, such as whipworms and hookworms, have been proposed as an alternative therapeu-
tic strategy (‘helminth therapy’) against some of these diseases5,6,8. For instance, experimental infections with the 
human hookworm Necator americanus have shown promise as a potential novel treatment for CeD4. Improved 
gluten tolerance following hookworm infection was associated with suppressed pro-inflammatory cytokine 
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responses and increasing regulatory immune cell responses4. However, the biological and molecular mechanisms 
by which hookworms can suppress autoimmune diseases remain unclear and require further investigations.
One of these potential mechanisms is likely to rely on the production of immune-modulatory excretory/
secretory products (ES) by hookworms, which include homologues of mammalian C-type lectins, galectins and 
cytokines9–11; however, it is likely that other biological and environmental factors are involved in these processes. 
In particular, given the primary role played by gastrointestinal dysbiosis in the pathogenesis of CeD12, it has 
been proposed that one of the mechanisms by which hookworms can support intestinal immune homeostasis in 
inflammatory disorders (such as CeD), is via the alteration of the composition of the gut microbiota and relative 
abundance of individual microbial species8,13–17. This hypothesis is based on the results of recent studies by us and 
others, in which experimental infections with gastrointestinal helminths were accompanied by detectable changes 
in commensal bacterial composition of both human and animal hosts13,14,17–20, as well as of the metabolic profiles 
of bacterial communities which indirectly promote the development of host regulatory T-cell responses21. In our 
previous study, experimental hookworm infection of human volunteers with CeD and administration of progres-
sively increasing doses of dietary gluten resulted in maintenance of the composition of the gut flora, as determined 
from faecal samples from these subjects14. However, we also observed a significant increase in microbial species 
richness over the course of the trial14, which is generally associated with a ‘healthier’ intestinal status22. These 
findings were based on analyses of bacterial community profiles from faecal samples of CeD subjects14. While 
the collection of such samples presents numerous practical advantages, the nature of the microbiota within the 
faeces may not accurately reflect the dynamic changes in bacterial communities that may occur in the duodenal 
tissue following hookworm infection or gluten challenge. Therefore, the aim of this study was to investigate alter-
ations in mucosally-associated (duodenal) microbiota of CeD subjects prior to and following experimental infec-
tion with N. americanus, as well as following the administration of a low (10–50 mg/day) and high (350 mg/day) 
dose of dietary gluten.
Results
Comparison of mucosally-associated bacteria in active Marsh 3 grade CeD Control and Trial 
subjects over the course of the experiment. All six Trial subjects included in the present study had 
been on a strict gluten free diet (GFD) for > 5 years and had recorded sub-clinical Marsh scores prior to the 
beginning of the study; all were successfully infected with N. americanus, with parasite eggs detectable in faeces 
from 8–52 weeks post-infection4. Duodenal biopsy samples were collected from these subjects prior to the infec-
tion (T0), as well as following the administration of 10–50 mg/day gluten from weeks 12–24 (T24) and twice-
weekly 1 g/day gluten from weeks 24 to 36 (approximately 350 mg gluten/day) (T36)4. Biopsy samples from six 
Control subjects from the same metropolitan area with active Marsh 3+ grade CeD were included for compara-
tive purposes (Supplementary Table S1). A total of 19,562,372 paired-end reads were generated from the 24 sam-
ples analyzed (per sample mean 815,099 ± 236,697) (not shown). After primer trimming, joining of paired-end 
reads and filtering of low-quality sequences, a total of 3,861,592 high-quality sequences were subjected to further 
bioinformatics analyses. Of these, 2,815,504 reads (~73%) were assigned to operational taxonomic units (OTUs) 
belonging to the families Bradyrhizobiaceae and Burkholderiaceae, respectively (not shown). Since, in accord-
ance with previous reports23,24, these bacteria were identified as contaminants of ultrapure water systems and/or 
DNA extraction kits, reads assigned to these OTUs were computationally subtracted from the dataset. Despite the 
high proportion of contaminant sequences in our datasets, rarefaction analysis demonstrated that the sequence 
data well covered the microbial diversity of the samples. Indeed, the rarefaction curves generated following 
in silico subtraction of these sequences indicated that the vast majority of mucosally-associated bacterial com-
munities were represented in the remaining sequence data, thus allowing us to undertake further analyses. The 
remaining 1,046,088 sequences were assigned to 5,338 OTUs and 6 bacterial phyla, respectively (Supplementary 
Dataset 1). The composition of the mucosally-associated microbiota of the Trial subjects over the course of the 
study, and of Control subjects is shown in Supplementary Figure S1. The phyla Proteobacteria, Bacteroidetes and 
Firmicutes were predominant in all samples analysed, the latter two also being identified as predominant in our 
previous investigation of the faecal microbiota of the same study subjects4,13,14. Significant differences in abun-
dance of individual taxa at the class, order and family level were observed between Trial subjects at baseline T0 
(i.e. prior to hookworm infection and exposure to escalating doses of gluten) and Control subjects (subjects with 
active CeD) by LDA Effect Size (LEfSe) analysis (FDR < 0.05) (Fig. 1A). Also, analysis by paired t-test identified 
differences in abundance of individual taxa at the phylum, class and order level between Control subjects and 
Trial subjects at T0, albeit these differences were not significant following p-value correction for multiple testing 
(FDR > 0.05). In particular, Actinobacteria (phylum), Actinobacteria, unclassified 4C0d.2 and Betaproteobacteria 
(class), Actinomycetales, unclassified MLE1.12 and Lactobacillales (order), showed a trend towards increased 
abundance in Trial subjects compared with Control subjects by paired t-test (Fig. 1B). OTU richness was signifi-
cantly higher in Trial subjects at T0 when compared to Controls (p = 0.026, t-test) (Fig. 1C).
Composition of the mucosally-associated microbiota of Trial subjects over the course of the 
experiment. Differences in the relative abundance of two classes, two orders, two families, one genus and 
12 OTUs were observed in Trial subjects over the course of the experiment, using the mixed effect linear regres-
sion method (Fig. 2 and Supplementary Table S2); in particular, Bacteroidia and Flavobacteriia (class) and 
Bacteroidales and Flavobacteriales (order) displayed a trend towards increased abundance in Trial subjects at 
T24 compared with T0 (FDR < 0.05) (Fig. 2).
Hookworm infection and gluten challenge are associated with a trend towards increased 
bacterial richness and diversity. We next assessed longitudinal changes in microbial diversity in Trial 
subjects both pre-trial, and following hookworm infection and gluten challenge. Using linear mixed effects 
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regression, we observed significant changes in microbial diversity (Shannon and Simpson index) and evenness 
over the course of the trial (Fig. 3). We also observed changes in OTU richness, which almost reached statistical 
significance (p = 0.07, Fig. 3). At week 24 (post-hookworm infection and gluten microchallenge) we observed a 
significant increase in OTU diversity (Shannon index p = 0.019, Simpson index p = 0.024; paired t-test) com-
pared to T0 samples. At week 36 (post-350 mg/d gluten challenge), OTU diversity returned to baseline T0 levels 
(Fig. 3, paired t-test T0 vs T24, Shannon and Simpson index p > 0.5).
Cluster analysis reveals time-point grouping of samples from Trial subjects. Mucosally-associated 
microbial communities were grouped by hierarchical clustering and ordinated by unsupervised non-metric mul-
tidimensional scaling (NMDS). The latter revealed that microbial samples from Control and Trial subjects formed 
separate clusters and samples from Trial subjects showed a tendency to cluster by time point (Fig. 4). Redundancy 
analysis (RDA), canonical correlation analysis (CCA) and Adonis confirmed this observation, as all three meth-
ods identified a significant association between community composition and sample time point (RDA, CCA, 
Adonis; p ≤ 0.045). RDA and CCA were able to clearly separate biopsy samples by time point (cf. Fig. 5). These 
results suggest a correlation between infection status and exposure to escalating doses of gluten and the compo-
sition of the gut microbiota.
Discussion
In this study we assessed, for the first time, the effects of experimental hookworm infection and gluten ingestion 
on the nature of the duodenal tissue-associated microbiota of CeD subjects. The unique opportunity to assess 
changes in bacterial communities at the site of hookworm infection and CeD-associated inflammation is of cru-
cial importance for dissecting the putative direct and/or indirect role/s of the gut microbiota in helminth-driven 
Figure 1. Differences between the mucosally-associated microbiota of Trial and Control subjects, and of 
Trial subjects over the course of the experiment. Differences in abundance of mucosally-associated bacteria 
(at the phylum- I, class – II, order - III and family – IV level) between Trial subjects prior to hookworm 
infection (T0) and of active coeliac disease Control subjects, based on LDA Effect Size (LEfSe) analysis  
(A) and paired t-test (B), with differences pre FDR indicated by the respective p-values. (C) Differences in 
overall taxonomic species richness (left panel) and diversity (right panel) between the mucosally-associated 
microbiota of Trial subjects prior to hookworm infection (T0) and that of Control subjects with active coeliac 
disease. Significant differences are indicated with asterisks (*p < 0.05).
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suppression of inflammation. We observed qualitative and quantitative changes in the composition of the 
tissue-resident microbiota from subjects with active, Marsh 3+ grade CeD compared to the Trial subjects who 
had well-managed CeD due to long-term adherence to a GFD. Interestingly, hookworm infection and gluten 
exposure in Trial subjects was associated with fluctuations in bacterial species richness and diversity, and trends 
towards increased abundance of species within the Bacteroides phylum, similar to previous reports analyzing the 
faeces of helminth-infected humans and primates14,18. Together, these data suggest that helminth infections and 
gluten exposure can significantly alter the composition of the tissue-resident and faecal microbiota, which has 
implications for the purported therapeutic efficacy of helminths in inflammatory disease.
Given that CeD diagnosis necessitates the collection of gut biopsy tissue, several studies have used this oppor-
tunity to characterize the mucosal microbiota in CeD patients, allowing for direct comparison of faecal and 
tissue microbiota in some instances. While some studies have shown consistency between the faecal and tissue 
microbiota in CeD patients25, others have shown substantial differences26,27, which would be expected given the 
distinct anatomical locations28,29. These findings clearly demonstrate the utility of analyzing both the faecal and 
tissue microbiota where possible. In the present investigation, we extended on our previous published analyses of 
Figure 2. Differences between the mucosally-associated microbiota of Trial subjects over the course of the 
experiment. Differences in abundance of mucosally-associated bacteria, at the class (A), order (B), family (C) 
and genus (D) level, between the mucosally-associated microbiota of Trial subjects prior to hookworm infection 
(T0) and post-gluten challenge (T24 and T36).
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the faecal microbiota13,14; however, given the profound methodological differences between this and our previous 
works13,14, direct comparisons of the results obtained are unwarranted.
Here, we compared the composition of the mucosally-associated microbiota of Trial subjects, prior to hook-
worm infection and exposure to dietary gluten (T0), to that of Control subjects. The mucosally-associated 
microbiota of the former group showed a trend towards higher numbers of Actinobacteria (phylum level), 
Actinobacteria and the unclassified 4C0d.2 (class), and Actinomycetales, the unclassified MLE1.12 and 
Lactobacillales (order) (cf. Fig. 1). The phylum Actinobacteria is one of the most abundant phyla in the gut 
commensal flora of humans30, and is enriched in the upper intestine when compared to other intestinal sites31. 
The phylum includes pathogens, such as the genus Mycobacterium, responsible for a diverse range of diseases in 
humans and animals, and gastrointestinal commensals, such as bacteria within the family Bifidobacteriaceae, 
which are characterized by well known probiotic properties due to their ability to ferment oligosaccharides32, as 
well as to modulate the immune system of their human hosts33. Increased concentrations of bifidobacteria have 
been reported in the duodenum of children with non-active CeD (i.e. on a strict GFD since > 2 years) when com-
pared with both children with active CeD and healthy controls; such observations led to the hypothesis that these 
bacterial populations may be partially restored following the introduction of a GFD25. However, in another study, 
the differences in concentration of duodenal Actinobacteria between CeD patients on a GFD with and without 
persistent symptoms were statistically insignificant34. Among others, methodological differences between these 
Figure 3. Trends towards increased bacterial richness and diversity are observed in Trial subjects post-
hookworm infection and gluten challenge. Differences in overall taxonomic species richness and diversity 
between the mucosally-associated microbiota of Trial subjects prior to hookworm infection (T0) and post-
gluten challenge (T24 and T36).
Figure 4. Unsupervised NMDS analysis. Unsupervised NMDS analysis of the composition of the mucosally-
associated microbiota of Trial subjects prior to hookworm infection (T0) and following exposure to escalating 
doses of dietary gluten (T24 and T36, respectively), as well as of Control subjects with active coeliac disease, 
ordered by time point (left panel), and subject ID (right panel), respectively.
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studies, i.e. bifidobacteria-targeted real-time PCR25 versus 16S rRNA gene pyrosequencing34, may have contrib-
uted to this discrepancy. The present study contained too few samples to allow us to draw definite conclusions 
about the effects of a GFD or the grade of active CeD on Actinobacteria populations in Trial and Control subjects. 
Similarly, lactobacilli appeared to be less prevalent in the active CeD Controls compared to our Trial subjects 
with diet-managed CeD. This group of bacteria is of particular interest in CeD research, as it includes known 
probiotics shown to exert a positive impact on a range of gastrointestinal inflammatory conditions, such as those 
caused by IBD and rotavirus infections35,36. Lactobacilli are decreased in the duodenal and faecal microbiota of 
CeD children (with active disease) compared with CeD children on a GFD, as well as with healthy controls25,26, 
which supports the hypothesis that the adherence to a strict GFD contributes to the restoration of a ‘healthy’ 
intestinal flora25.
We characterized the qualitative and quantitative fluctuations in the composition of mucosally-associated 
microbiota of Trial subjects experimentally infected with hookworms and exposed to progressively increasing 
doses of dietary gluten. Compared with biopsy samples collected from Trial subjects at T0 (i.e. prior to experi-
mental infections), those collected following hookworm infection and gluten micro-challenge (T24) displayed 
higher relative abundances of the orders Bacteroidales and Flavobacteriales, of the Bacteroides phylum. Bacteria 
within this phylum were also increased in the faecal microbiota (assessed by 16S rRNA high-throughput sequenc-
ing) of macaques with idiopathic chronic diarrhea (ICD) after experimental infection with Trichuris whipworms, 
when compared with uninfected controls exhibiting clinical signs of disease18. However, in the same study, eval-
uation of absolute Bacteroidetes abundance by real-time PCR displayed a reduction in the populations of these 
bacteria in the faeces of macaques post-Trichuris treatment, which led the authors to hypothesize that the appar-
ent increase observed by high-throughput sequencing of the 16S rRNA gene might have reflected an expansion of 
non-Bacteroidetes phyla in diseased subjects18. More recent studies in murine models and in human populations 
have supported a role for Trichuris in regulating the balance of Bacteroidetes within the gut, while simultaneously 
promoting Clostridiales colonization17. Nonetheless, in our study, a larger relative abundance of Bacteroidetes 
was detected in Trial subjects at both T0 and following the introduction of an inflammatory stimulus (i.e. gluten, 
T24). Based on our preliminary observations, as well as knowledge that these bacteria are more abundant in CeD 
subjects displaying no symptoms of disease compared with symptomatic controls26,34 we hypothesize that the rel-
ative expansion of populations of Bacteroidetes between T0 and T24 may be associated with helminth infections. 
Figure 5. Supervised RDA and CCA analyses reveal clustering according to time points. Supervised 
RDA (A) and CCA (B) depicting the composition of the mucosally-associated microbiota of Trial subjects 
prior to hookworm infection (T0) and following exposure to escalating doses of dietary gluten (T24 and T36, 
respectively), as well as of Control subjects with active coeliac disease, ordered by time point (left panels), and 
subject ID (right panels), respectively.
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Consistent with this, exposure to gluten challenges in trial subjects was not accompanied by an expansion of 
Betaproteobacteria that were abundant in the mucosally-associated microbiota of Control subjects with CeD. 
This finding leads us to hypothesize that hookworms may indeed contribute towards the maintenance of the gut 
homeostasis in presence of an inflammatory insult. However, these hypotheses require testing in larger, placebo 
controlled, clinical trials.
Fluctuations in overall bacterial diversity and richness were observed between biopsy samples from Control 
and Trial subjects at T0, and Trial subjects at T0, T24 and T36. In particular, richness was significantly higher in 
Trial subjects at T0 when compared to Controls, while samples from Trial subjects at T24 displayed a significant 
increase in OTU diversity compared to T0 samples. Diversity returned to baseline T0 levels at T36. The observed 
difference in bacterial richness between Control and Trial subjects at T0 is in overall agreement with the results 
of a number of previous studies on the composition of the gut microbiota of individuals suffering from a range 
of inflammatory intestinal disorders, including CeD and IBD37–39, and it generally reflects a ‘healthier’ intestinal 
homeostasis40. Similarly, the observed differences in bacterial diversity in Trial subjects at T24 compared with 
T0 is also in agreement with our previous observations on the faecal microbiota of the same subjects14, and sup-
ports our previous hypothesis that the ability of hookworms to act as a gluten-tolerising agents in CeD subjects4 
may partly be linked to their direct and/or indirect capacity to promote the restoration of a healthy bacterial 
diversity and richness in the gastrointestinal tract8. In support of this hypothesis, a previous study by Broadhurst 
et al.18 also showed that the gut microbiota of Trichuris-infected macaques with ICD was characterized by a 
significantly higher bacterial diversity and richness when compared to uninfected controls, which the authors 
attributed to the symptomatic improvement observed in the former group18. Moreover, in a separate study inves-
tigating the composition of the faecal microbiota in humans naturally infected with gastrointestinal parasitic 
helminths, Lee et al.41 also detected a significantly higher bacterial richness in the microbiota of subjects from 
indigenous Malaysian communities with natural infections with Trichuris and/or hookworms and/or Ascaris sp. 
compared with uninfected subjects from the same geographical area41. It is also worth noting that, in the study 
by Broadhurst et al.18, the initial infection dose consisted of ~1000 T. suis ova and, while in the study by Lee 
et al.41 a precise estimation of the infection burdens affecting the subjects tested would be highly speculative, 
this is likely to be substantially higher than the hookworm infection dose that was inoculated into Trial subjects 
enrolled in our study (20 infective larvae overall). This observation further substantiates the role of hookworms 
as potent inducers of host responses9, which may also be reflected in their capacity to alter the gut microbiota of 
infected individuals. In a recent experiment, changes in metabolites produced by the gut microbiota of the same 
cohort of Trial subjects investigated in both this and our previous study14 were examined21. The results showed 
that the faecal samples of 4 out of 6 Trial subjects whose mucosally-associated microbiota was examined herein, 
were characterized by increased levels of short-chain fatty acids (SCFA), which were reflected by changes in the 
concentrations of acetate, propionate and butyrate) post-hookworm infection compared with T0 baseline levels21. 
These metabolites have been demonstrated to exert anti-inflammatory properties by promoting host regulatory 
T cell responses21,42–45. It is therefore plausible that factors linked to the increase in microbial diversity and rich-
ness, as well as in microbial anti-inflammatory metabolites contribute synergistically to the ability of hookworms 
to dampen inflammatory reactions and establish chronic infections in the human host. However, in our study, 
we also observed a significant decrease in bacterial diversity and richness at T36 (following gluten challenge) 
compared with T24 (following hookworm infection and gluten micro-challenge), albeit the latter difference was 
statistically insignificant. This finding may be associated with the onset of inflammatory responses that occurred 
in Trial subjects at T36, as a consequence of the substantial increase in the doses of dietary gluten to which they 
had been exposed (350 mg daily from T24 to T36 vs 10 to 50 mg daily up to T24)4. Nevertheless, in 5 out of 6 Trial 
subjects included in the present study, the duodenal villous height:crypth depth ratio (Vh:Cd), i.e. a measure 
of the mucosal inflammation and intestinal pathology46, was improved or unaltered following gluten challenge 
compared with biopsy samples collected post-gluten microchallenge (T24)4, possibly indicating that the compo-
sition of the gut microbiota reacts rapidly in response to dietary changes and/or inflammatory stimuli. Data on 
the levels of SCFA in faecal samples from Trial subjects following exposure to dietary gluten are unavailable21, 
therefore a correlation between such levels and the observed decrease in microbial diversity and richness at T36 
could not be established.
Some limitations of our study, as for our previous investigations on the faecal microbiota of the same Trial sub-
jects4,13,14, were (i) the small sample size, which may have prevented us from detecting significant differences in 
the composition of the mucosally-associated microbiota of hookworm-infected CeD subjects exposed to increas-
ing doses of dietary gluten; (ii) the unavailability of duodenal biopsy samples collected following hookworm 
establishment but prior to gluten challenge, which affected our ability to clearly separate the effects of helminth 
infection and the introduction of an inflammatory stimulus on the composition of the mucosally-associated 
microbiota; and (iii) the absence of hookworm- and gluten-placebo cohorts of subjects. Therefore, while the 
observations from the present study are promising, larger placebo-controlled clinical trials are necessary to con-
firm or confute our hypotheses regarding the putative role(s) of the gut microbiota in such mechanisms.
Methods
Ethics statement. This study was approved and carried out in strict accordance and compliance with 
the National Statement on Ethical Conduct in Research Involving Humans guidelines of the National Health 
and Medical Research Council of Australia (NHMRC). The Prince Charles Hospital (Brisbane, Australia) and 
James Cook University Human Research Ethics Committees approved the study. Written informed consent was 
obtained from all subjects enrolled in the study. This study was registered as a clinical trial at ClinicalTrials.gov 
as NCT016619334.
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Trial design. Six otherwise healthy volunteers with CeD (HLA-DQ2+ or HLA-DQ8+ ) on a strict GFD 
(> 5 years) (= Trial subjects) were infected percutaneously with 20 infective third stage larvae of N. americanus4. 
Subjects then underwent exposure to escalating doses of dietary gluten (as spaghetti), with a 10–50 mg/day 
micro-challenge from weeks 12–24, followed by intermittent twice-weekly 1 g/day gluten challenge from weeks 
24 to 36 (approximately 350 mg gluten/day)4. Prior to experimental infection (T0), as well as at 24 (T24) and 36 
weeks (T36) post-infection, two individual biopsy samples were collected from a randomly selected region of 
the duodenum of each subject by an accredited gastroenterologist (J. Croese) supported by an anaesthetist in 
an accredited facility (Prince Charles Hospital, Brisbane, Australia) and stored at −80 °C in Trizol solution. In 
addition, individual duodenal biopsy samples from six hookworm-naïve volunteers with active CeD (diagnosed 
as Marsh grade 3 at the time of biopsy)4 (= Control subjects) were also included for comparative purposes. A 
list of subject IDs whose mucosally-associated microbiota were analysed in the present study is presented in 
Supplementary Table S1.
DNA extraction and 16S Illumina sequencing. Genomic DNA was extracted directly from each sample, 
as well as from two negative controls, using the Trizol RNA/DNA extraction kit, according to manufacturers’ 
instructions. High-throughput sequencing of the V3-V4 hypervariable region of the bacterial 16S rRNA gene was 
performed on an Illumina MiSeq platform according to the manufacturers’ protocols with minor adjustments. 
Briefly, the V3-V4 region was PCR-amplified using universal primers47, that contained the Illumina adapter over-
hang nucleotide sequences, using the NEBNext hot start high-fidelity DNA polymerase (New England Biolabs) 
and the following thermocycling protocol: 2 min at 98 °C, 35 cycles of 15 s at 98 °C – 30 s at 63 °C – 30 s at 72 °C, 
and a final elongation of 5 min at 72 °C. Amplicons were purified using AMPure XP beads (Beckman Coulter) and 
the NEBNext hot start high-fidelity DNA polymerase was used for the index PCR with Nextera XT index prim-
ers (Illumina) according to the following thermocycling protocol: 30 s at 98 °C, 8 cycles of 10 s at 98 °C – 75 s at 
65 °C, and 5 min at 65 °C. The indexed samples were purified using AMPure XP beads, quantified using the Qubit 
dsDNA broad range kit (Life Technologies), and equal quantities from each sample were pooled. The resulting 
pooled library was quantified using the NEBNext library quantification kit (New England Biolabs) and sequenced 
on an Illumina MiSeq platform using the v3 chemistry (301 bp paired-end reads). Raw sequence data have been 
deposited in the NCBI Sequence Read Archive database under accession number SRP078558.
Bioinformatics analyses. Raw paired-end Illumina reads were trimmed for 16S rRNA gene primer 
sequences using Cutadapt (https://cutadapt.readthedocs.org/en/stable/) and reads were joined using FLASH 
(https://ccb.jhu.edu/software/FLASH/)48. Pre-processed sequence data were processed using the Quantitative 
Insights Into Microbial Ecology (QIIME) software suite49. Successfully joined sequences were quality filtered 
in QIIME using default settings. Then, sequences were clustered into OTUs on the basis of similarity to known 
bacterial sequences available in the Greengenes database (v13.8; http://greengenes.secondgenome.com/; 97% 
sequence similarity cut-off) using the UCLUST software; sequences that could not be matched to references in 
the Greengenes database were clustered de novo based on pair-wise sequence identity (97% sequence similarity 
cut-off). The first selected cluster seed was considered as the representative sequence of each OTU. Then, repre-
sentative sequences were assigned to taxonomy using the UCLUST software. Singleton OTUs were removed prior 
to downstream analysis. Normalisation was carried out by generating a subsampled OTU table by random sam-
pling (without replacement) of the input OTU table using an implementation of the Mersenne twister algorithm 
(http://www.numpy.org/). Subsequently, OTU tables were rarefied to accommodate for different sampling depths. 
Samples characterised by fewer than the requested rarefaction depth (i.e. 10,666 sequences) were omitted from 
the output OTU table. Statistical analyses were executed in R version 3.1.2 (http://www.r-project.org/); normality 
of variables was tested by Shapiro test and equality of variance by Levene test. The mean abundance of each taxon 
across different time points was analysed by Repeated Measured ANOVA for taxa with normal distribution and 
equal variance, and by the non-parametric Friedmann test for taxa for which these two assumptions were not 
fulfilled. Differences in abundance of individual taxa were assessed by paired t-test if the differences between 
the pairs were normally distributed and by Wilcoxon test for non-normally distributed differences between 
pairs. p-values were corrected for multiple testing by holm adjustment. Further statistical analyses were executed 
using the Calypso software (cgenome.net/calypso/); in particular, unsupervised hierarchical clustering, as well as 
NMDS analysis, were performed to obtain an overview of the distribution of samples according to sample origin 
and time points. ANOSIM was used to compare the overall composition of microbiota across subjects and time 
points. Supervised RDA (including subject and time point as explanatory variables), CCA, Adonis and Anosim 
were applied on the OTU table in the Calypso software with default parameters. Differences in the composition 
of the mucosally-associated microbiota between Control and Trial subjects (prior to hookworm infection and 
gluten challenge only, i.e. T0) were assessed using the LEfSe workflow50, by assigning ‘helminth infection status’ as 
comparison class. Changes in bacterial diversity and richness in Trial subjects over the course of the experiment 
(i.e. at T0, T24 and T36), as well as of longitudinal changes in the abundance of individual taxa, were evaluated 
using paired t-test and mixed effects linear regression (in order to account for correlations between repeated 
measures on the same subjects)51. Mixed effects linear regression models included taxa abundance (or diversity) 
as dependent variable, time point as fixed effect and individual as random effect.
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